Long-term testosterone therapy does not increase the risk of prostate cancer
Long-term testosterone therapy does not increase the risk of prostate cancer New York, NY, November 25, 2014 – Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are…